Literature DB >> 17932159

Device therapy in heart failure.

Finlay A McAlister.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17932159      PMCID： PMC2048892          DOI： 10.1136/bmj.39353.546933.BE

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  12 in total

1.  How many patients with heart failure are eligible for cardiac resynchronization? Insights from two prospective cohorts.

Authors:  Finlay A McAlister; Jack V Tu; Alice Newman; Douglas S Lee; Shane Kimber; Bibiana Cujec; Paul W Armstrong
Journal:  Eur Heart J       Date:  2005-08-16       Impact factor: 29.983

2.  Safety issues involving medical devices: implications of recent implantable cardioverter-defibrillator malfunctions.

Authors:  William H Maisel
Journal:  JAMA       Date:  2005-08-24       Impact factor: 56.272

3.  Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase].

Authors:  John G F Cleland; Jean-Claude Daubert; Erland Erdmann; Nick Freemantle; Daniel Gras; Lukas Kappenberger; Luigi Tavazzi
Journal:  Eur Heart J       Date:  2006-06-16       Impact factor: 29.983

4.  Implantable cardioverter-defibrillators for primary prevention of sudden death in heart failure: are there enough bangs for the bucks?

Authors:  Lynne Warner Stevenson
Journal:  Circulation       Date:  2006-07-11       Impact factor: 29.690

5.  Characteristics of patients who die with heart failure and a low ejection fraction in the new millennium.

Authors:  Jeffrey J Teuteberg; Eldrin F Lewis; Anju Nohria; Sui W Tsang; James C Fang; Michael M Givertz; John A Jarcho; Gilbert H Mudge; Kenneth L Baughman; Lynne W Stevenson
Journal:  J Card Fail       Date:  2006-02       Impact factor: 5.712

6.  The frequency and incremental cost of major complications among medicare beneficiaries receiving implantable cardioverter-defibrillators.

Authors:  Matthew R Reynolds; David J Cohen; Aaron D Kugelmass; Phillip P Brown; Edmund R Becker; Steven D Culler; April W Simon
Journal:  J Am Coll Cardiol       Date:  2006-05-30       Impact factor: 24.094

Review 7.  The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.

Authors:  M Fox; S Mealing; R Anderson; J Dean; K Stein; A Price; R S Taylor
Journal:  Health Technol Assess       Date:  2007-11       Impact factor: 4.014

Review 8.  Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction: a systematic review.

Authors:  Finlay A McAlister; Justin Ezekowitz; Nicola Hooton; Ben Vandermeer; Carol Spooner; Donna M Dryden; Richard L Page; Mark A Hlatky; Brian H Rowe
Journal:  JAMA       Date:  2007-06-13       Impact factor: 56.272

Review 9.  Systematic review: implantable cardioverter defibrillators for adults with left ventricular systolic dysfunction.

Authors:  Justin A Ezekowitz; Brian H Rowe; Donna M Dryden; Nicola Hooton; Ben Vandermeer; Carol Spooner; Finlay A McAlister
Journal:  Ann Intern Med       Date:  2007-08-21       Impact factor: 25.391

Review 10.  Combined resynchronisation and implantable defibrillator therapy in left ventricular dysfunction: Bayesian network meta-analysis of randomised controlled trials.

Authors:  Simon K H Lam; Andrew Owen
Journal:  BMJ       Date:  2007-10-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.